Release of Enterococcus mundtii Bacteriocin ST4SA from Self-Setting Brushite Bone Cement

Probiotics and Antimicrobial Proteins

Volumn 3, Issue 2, 2011, Pages 119-124

  van Staden, Anton D ^a   Heunis, Tiaan D J ^a   Dicks, Leon M T ^a,b  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b NONE   (South Africa)

Author keywords

Antimicrobial activity; Bacteriocin; Brushite bone cement

Indexed keywords

BACTERIOCIN; BONE CEMENT; CALCIUM PHOSPHATE DIBASIC;

ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG IMPLANTATION; ENTEROCOCCUS; ENTEROCOCCUS MUNDTII; IN VITRO STUDY; MATERIAL STATE; NONHUMAN; PRIORITY JOURNAL; TIMED DRUG RELEASE;

ENTEROCOCCUS MUNDTII;

EID: 79958779824     PISSN: 18671306     EISSN: 18671314     Source Type: Journal    
DOI: 10.1007/s12602-011-9074-7     Document Type: Article

References (38)

1. Albano H, Todorov SD, van Reenen CA, Hogg T, Dicks LMT, Teixeira P (2007) Characterization of two bacteriocins produced by Pediococcus acidilactici isolated from "Alheira", a fermented sausage traditionally produced in Portugal. Int J Food Microbiol 116: 239-247.
2. Alkhraisat MH, Rueda C, Marino FT, Torres J, Jerez LB, Gbureck U, Cabarcos EL (2009) The effect of hyaluronic acid on brushite cement cohesion. Acta Biomater 5: 3150-3156.
3. Barralet J, Grover L, Gbureck U (2004) Ionic modification of calcium phosphate cement viscosity. Part II: hypodermic injection and strength improvement of brushite cement. Biomaterials 25: 2197-2203.
4. Bauer R, Dicks LMT (2005) Mode of action of lipid II-targeting lantibiotics. Int J Food Microbiol 101: 201-216.
5. Bayston R, Milner R (1982) The sustained release of antimicrobial drugs from bone cement. An appraisal of laboratory investigations and their significance. J Bone Joint Surg (Br) 64: 460-465.
6. Bohner M, Lemaître J, van Landuyt P, Zambelli PY, Merkle HP, Gander B (1997) Gentamicin-loaded hydraulic calcium phosphate bone cement as antibiotic delivery system. J Pharm Sci 86: 565-572.
7. Brand AM, De Kwaadsteniet M, Dicks LMT (2010) The ability of nisin F to control Staphylococcus aureus infection in the peritoneal cavity, as studied in mice. Lett Appl Microbiol 51: 645-649.
8. Chambers T, Thomson B, Fuller K (1984) Effect of substrate composition on bone resorption by rabbit osteoclasts. J Cell Sci 70: 61-71.
9. Chen H, Hoover D (2003) Bacteriocins and their food applications. Compr Rev Food Sci Food Safety 2: 82-100.
10. Cotter PD, Hill C, Ross RP (2005) Bacteriocins: developing innate immunity for food. Nat Rev Microbiol 3: 777-788.
11. De Kwaadsteniet M, Doeschate K, Dicks LMT (2009) Nisin F in the treatment of respiratory tract infections caused by Staphylococcus aureus. Lett Appl Microbiol 48: 65-70.
12. De la Riva B, Sánchez E, Hernández A, Reyes R, Tamimi F, López-Cabarcos E, Delgado A, Évora C (2009) Local controlled release of VEGF and PDGF from a combined brushite-chitosan system enhances bone regeneration. J Controlled Rel 143: 45-52.
13. Espehaug B, Engesaeter L, Vollset S, Havelin L, Langeland N (1997) Antibiotic prophylaxis in total hip arthroplasty: review of 10 905 primary cemented total hip replacements reported to the Norwegian arthroplasty register, 1987 to 1995. J Bone Joint Surg (Br) 79: 590-595.
14. Frommelt L, Kühn KD (2005) Properties of bone cements: antibiotic-loaded bone cements. In: Breusch SJ, Malchau H (eds) The well-cemented total hip arthoplasty: theory and practice. Springer Medizin, Germany, pp 86-92.
15. Fullana G, Ternet H, Freche M, Lacout JL, Rodriguez F (2010) Controlled release properties and final macroporosity of a pectin microspheres-calcium phosphate composite bone cement. Acta Biomater 6: 2294-2300.
16. Ginebra M, Traykova T, Planell J (2006) Calcium phosphate cements as bone drug delivery systems: a review. J Controlled Rel 113: 102-110.
17. Górecki A, Babiak I (2008) Infection of joint prosthesis and local drug delivery. In: Kienapfel H, Kühn KD (eds) The infected implant. Springer Medizin, Germany, pp 19-26.
18. Hamanishi C, Kitamoto K, Tanaka S, Otsuka M, Doi Y, Kitahashi T (1996) A self-setting TTCP-DCPD apatite cement for release of vancomycin. J Biomed Mater Res-B 33: 139-143.
19. Hanssen AD, Rand JA, Osmon DR (1994) Treatment of the infected total knee arthroplasty with insertion of another prosthesis: the effect of antibiotic-impregnated bone cement. Clin Orthop 309: 44-55.
20. Hofmann M, Mohammed A, Perrie Y, Gbureck U, Barralet J (2009) High-strength resorbable brushite bone cement with controlled drug-releasing capabilities. Acta Biomater 5: 43-49.
21. Klaenhammer TR (1993) Genetics of bacteriocins produced by lactic acid bacteria. FEMS Microbiol Rev 12: 39-85.
22. Knoetze H, Todorov SD, Dicks LMT (2008) A class IIa peptide from Enterococcus mundtii inhibits bacteria associated with otitis media. Int J Antimicrob Agents 31: 228-234.
23. Kruszewska D, Sahl HG, Bierbaum G, Pag U, Hynes SO, Ljungh Å (2004) Mersacidin eradicates methicillin-resistant Staphylococcus aureus (MRSA) in a mouse rhinitis model. J Antimicrob Chemother 54: 648-653.
24. Le Nihouannen D, Komarova SV, Gbureck U, Barralet JE (2008) Bioactivity of bone resorptive factor loaded on osteoconductive matrices: stability post-dehydration. E J Pharma Biopharm 70: 813-818.
25. Maniatis T, Fritsch EF, Sambrook J (1982) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
26. National Institutes of Health (1994) Total Hip Replacement. NIH Consensus Statement 12: 1-31.
27. Pierce AM, Lindskog S, Hammarström L (1991) Osteoclasts: structure and function. Electron Microsc Rev 4: 1-45.
28. Piper C, Hill C, Cotter PD, Ross RP (2010) Bioengineering of a Nisin A-producing Lactococcus lactis to create isogenic strains producing the natural variants Nisin F, Q and Z. Microb Biotech. doi: 10. 1111/j. 1751-7915. 2010. 00207.
29. Ruhe P, Boerman O, Russel F, Spauwen P, Mikos AG, Jansen JA (2005) Controlled release of rhBMP-2 loaded poly (dl-lactic-co-glycolic acid)/calcium phosphate cement composites in vivo. J Controlled Rel 106: 162-171.
30. Ruhe PQ, Hedberg EL, Padron NT, Spauwen PHM, Jansen JA, Mikos AG (2003) rhBMP-2 release from injectable poly (DL-lactic-co-glycolic acid)/calcium-phosphate cement composites. J Bone Joint Surg 85: 75-81.
31. 2 anti-solvent precipitation for sustained antimicrobial activity. Int J Pharm 287: 163-173.
32. Schnieders J, Gbureck U, Thull R, Kissel T (2006) Controlled release of gentamicin from calcium phosphate-poly (lactic acid-co-glycolic acid) composite bone cement. Biomaterials 27: 4239-4249.
33. Tamimi F, Torres J, Bettini R, Ruggera F, Rueda C, López-Ponce M, Lopez-Cabarcos E (2008) Doxycycline sustained release from brushite cements for the treatment of periodontal diseases. J Biomed Mater Res-A 85: 707-714.
34. Thornes B, Murray P, Bouchier-Hayes D (2004) Development of resistant strains of Staphylococcus epidermidis on gentamicin-loaded bone cement in vivo. J Bone Joint Surg (Br) 84: 758-760.
35. van Reenen CA, Chikindas ML, van Zyl WH, Dicks LMT (2003) Characterization and heterologous expression of a class IIa bacteriocin, plantaricin 423 from Lactobacillus plantarum 423, in Saccharomyces cerevisiae. Int J Food Microbiol 81: 29-40.
36. Young AM, Ng PYJ, Gbureck U, Nazhat SN, Barralet JE, Hofmann MP (2008) Characterization of chlorhexidine-releasing, fast-setting, brushite bone cements. Acta Biomater 4: 1081-1088.
37. Zimmerli W (2006) Prosthetic-joint-associated infections. Best Prac Res Cl Rh 20: 1045-1063.
38. Zimmerli W, Ochsner P (2003) Management of infection associated with prosthetic joints. Infection 31: 99-108.